FELICETTI, TOMMASO
 Distribuzione geografica
Continente #
NA - Nord America 798
EU - Europa 546
AS - Asia 351
AF - Africa 2
SA - Sud America 1
Totale 1.698
Nazione #
US - Stati Uniti d'America 798
IT - Italia 221
SG - Singapore 169
IE - Irlanda 150
HK - Hong Kong 100
BE - Belgio 33
CN - Cina 32
DE - Germania 30
SE - Svezia 27
VN - Vietnam 26
RU - Federazione Russa 20
KR - Corea 10
FI - Finlandia 9
GB - Regno Unito 9
RO - Romania 8
FR - Francia 7
PT - Portogallo 7
UA - Ucraina 7
CZ - Repubblica Ceca 5
CH - Svizzera 4
NL - Olanda 4
AT - Austria 3
IR - Iran 3
JP - Giappone 3
CI - Costa d'Avorio 2
IQ - Iraq 2
UZ - Uzbekistan 2
BG - Bulgaria 1
BR - Brasile 1
ID - Indonesia 1
LB - Libano 1
PK - Pakistan 1
PL - Polonia 1
TW - Taiwan 1
Totale 1.698
Città #
Chandler 221
Dublin 150
Singapore 135
Perugia 102
Hong Kong 96
Boardman 59
Santa Clara 49
San Mateo 44
Altamura 39
Brussels 33
Medford 29
Princeton 29
Lawrence 27
Dong Ket 25
Redmond 21
Wilmington 20
Spoleto 17
Redwood City 15
Andover 10
Des Moines 9
Fremont 9
Los Angeles 9
San Giustino 9
Ann Arbor 8
Beijing 8
Seoul 8
West Jordan 8
Bucharest 7
Dallas 7
New York 7
Helsinki 6
Saint Petersburg 6
Houston 5
Norwalk 5
Olomouc 5
Guarda 4
Hanover 4
Xian 4
Ashburn 3
Bologna 3
Foligno 3
Milan 3
Shanghai 3
Turin 3
Vigodarzere 3
Abidjan 2
Baghdad 2
Boydton 2
Campegine 2
Chongqing 2
Dearborn 2
Den Haag 2
Genova 2
Jacksonville 2
Jinan 2
London 2
Moscow 2
Padova 2
Rome 2
San Gemini 2
Setúbal 2
Umbertide 2
Vienna 2
Absecon 1
Amsterdam 1
Ardabil 1
Bastia umbra 1
Boston 1
Buffalo 1
Böblingen 1
Castello di Godego 1
Fairfield 1
Falkenstein 1
Falls Church 1
Frankfurt Am Main 1
Guangzhou 1
Hangzhou 1
Hanoi 1
Horia 1
Ispica 1
Jakarta 1
Kagoya 1
Kunming 1
Lisbon 1
Monmouth Junction 1
Munich 1
Nanchang 1
Pasadena 1
Philadelphia 1
Phoenix 1
Quanzhou 1
Romola 1
San Jose 1
San Paolo di Civitate 1
Seattle 1
Shenyang 1
Taipei 1
Tokyo 1
Zurich 1
Totale 1.342
Nome #
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 107
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 78
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 74
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 73
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 72
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 71
Deciphering the molecular recognition mechanism of multidrug resistance staphylococcus aureus nora efflux pump using a supervised molecular dynamics approach 66
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 63
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 62
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 60
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 59
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 58
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 57
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 55
Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View 53
Biofunctionalization of Poly(lactide-co-glycolic acid) Using Potent NorA Efflux Pump Inhibitors Immobilized on Nanometric Alpha-Zirconium Phosphate to Reduce Biofilm Formation 50
Investigation on the effect of known potent S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation 48
Ethidium bromide exposure unmasks an antibiotic efflux system in Rhodococcus equi 48
Building up efflux-mediated antimicrobial resistance in Staphylococcus pseudintermedius 44
Inhibition of Staphylococcus pseudintermedius Efflux Pumps by Using Staphylococcus aureus NorA Efflux Pump Inhibitors 42
Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants 42
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 41
Modulating microRNA Processing: Enoxacin, the Progenitor of a New Class of Drugs 41
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 40
Tumour cell population growth inhibition and cell death induction of functionalized 6-aminoquinolone derivatives 39
An overview on small molecules acting as broad-spectrum agents for yellow fever infection 38
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 38
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 31
Triazolopyrimidine nuclei: privileged scaffolds for developing antiviral agents with a proper pharmacokinetic profile. 30
Targeting miRNA dysregulation with small molecules: The case of enoxacin 28
Microbial efflux pump inhibitors: A journey around quinoline and indole derivatives 27
Protein-protein interactions by influenza polymerase subunits as drug targets 24
Fighting Antimicrobial Resistance: Insights on How the Staphylococcus aureus NorA Efflux Pump Recognizes 2-Phenylquinoline Inhibitors by Supervised Molecular Dynamics (SuMD) and Molecular Docking Simulations 24
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity 21
Drug efflux transporters in Staphylococcus pseudintermedius: in silico prediction and characterization of resistance 20
Functionalized sulfonyl anthranilic acid derivatives inhibit replication of all the four dengue serotypes 19
EVALUATION OF DRUG EFFLUX ACTIVITY IN ANTIMICROBIAL RESISTANT STAPHYLOCOCCUS PSEUDINTERMEDIUS CLINICAL ISOLATES 18
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 17
Discovery of 2‐phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate 16
Virucidal Activity of the Pyridobenzothiazolone Derivative HeE1-17Y against Enveloped RNA Viruses 16
Optimized Inhibitors of MDM2 via an Attempted Protein-Templated Reductive Amination 15
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines 14
Recent Progress toward the Discovery of Small Molecules as Novel Anti-Respiratory Syncytial Virus Agents 4
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization 4
Totale 1.847
Categoria #
all - tutte 9.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.371


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202043 0 0 0 0 1 5 13 2 4 15 2 1
2020/2021191 0 16 5 11 39 16 51 6 17 3 1 26
2021/2022311 10 35 6 11 13 2 44 69 29 16 30 46
2022/2023617 30 128 7 67 45 72 0 28 191 10 29 10
2023/2024339 20 54 16 5 8 12 93 7 14 26 36 48
2024/2025285 15 64 40 88 78 0 0 0 0 0 0 0
Totale 1.847